Otsuka Pharma announces positive phase 3b results for centanafadine in adults with ADHD and comorbid anxiety

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC) announced positive topline results in a phase 3b study (NCT06973577) evaluating